Chemical Compound

(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione

CAS Registry Number 7689-03-4
返回搜索 申请报价
(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione 结构式
Primary record

(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione

库存
6,956 克
纯度
98.8 %
CAS
7689-03-4

化合物标识与属性

CAS
7689-03-4
PubChem CID
24360
SMILES
CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O
Canonical SMILES
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1

名称与同义词

  • camptothecin
  • Camptothecine
  • (S)-(+)-Camptothecin
  • Campathecin
  • (+)-Camptothecin
  • d-Camptothecin
  • 7689-03-4
  • (+)-Camptothecine
  • 20(S)-Camptothecine
  • d-camptothecine
  • (s)-camptothecine
  • (S)-Camptothecin
  • ( )-Camptothecin
  • 20(S)-Camptothecin
  • Prestwick_102
  • Camptothecine (S,+)
  • CAMPTOTHECINUM
  • (+)-Camptothecin;
  • Fmoc-Lys(Tnm)-OH
  • (20S)-Camptothecin
  • Camptothecin derivative
  • Camptothecine (8CI)
  • CHEMBL65
  • Fmoc-Dap(Adpoc)-OH
  • Spectrum_000299
  • Tocris-1100
  • Topotecan Related Compound C
  • 20-(S)-camptothecine
  • ethyl(hydroxy)[?]dione
  • SpecPlus_000712
  • AC1L2NDR
  • NSC94600
  • Prestwick0_000200
  • Prestwick1_000200
  • Prestwick2_000200
  • Prestwick3_000200
  • RefChem:388854
  • Spectrum2_000903
  • Spectrum3_001203
  • Spectrum4_000738
  • Spectrum5_001126
  • CAMPTOTHECIN [MI]
  • Lopac-C-9911
  • XT3Z54Z28A
  • VSJKWCGYPAHWDS-FQEVSTJZSA-N
  • DTXSID0030956
  • MFCD00081076
  • NSC-94600
  • D09YDM
  • 21,22-Secocamptothecin-21-oic acid lactone
  • AC1Q2C5X
  • MLS000766223
  • SCHEMBL6038
  • UNII-XT3Z54Z28A
  • Lopac0_000341
  • BSPBio_000159
  • BSPBio_002586
  • KBioGR_001036
  • KBioSS_000779
  • KBioSS_002283
  • CHEBI:27656
  • cid_24360
  • CAMPTOTHECIN [WHO-DD]
  • DivK1c_000826
  • DivK1c_006808
  • SPECTRUM1502232
  • SPBio_000746
  • SPBio_002080
  • AC1Q2C60
  • BPBio1_000175
  • C20H16N2O4
  • Camptothecin, Camptotheca acuminata
  • CCRIS 8162
  • orb1309690
  • Jsp000050
  • DTXCID8010956
  • SCHEMBL29351099
  • SCHEMBL29360250
  • ERK5-6L18
  • HMS502J08
  • KBio1_000826
  • KBio1_001752
  • KBio2_000779
  • KBio2_003347
  • KBio2_005915
  • KBio3_002086
  • NINDS_000826
  • Bio1_000400
  • Bio1_000889
  • Bio1_001378
  • GLXC-10346
  • HMS1568H21
  • HMS1921N08
  • HMS2089F08
  • HMS2095H21
  • HMS3261E03
  • HMS3414J17
  • HMS3654D13
  • HMS3678J15
  • HMS3712H21
  • ZINC105309
  • NSC 100880
  • ACT02668
  • BCP02857
  • CID24360
  • MSK40312
  • Tox21_500341
  • AC-202
  • BBL033963
  • BDBM50008923
  • CCG-40255
  • CID:24360
  • EBC-14151
  • GR-301
  • MFCD00013554
  • NSC 94600
  • s1288
  • STK801886
  • AKOS004119861
  • ACN-035664
  • Camptothecin; Irinotecan EP Impurity D
  • CS-1049
  • DB04690
  • FC15450
  • J2.266G
  • KS-5235
  • LP00341
  • SDCCGMLS-0066688.P001
  • SDCCGSBI-0050329.P003
  • BRN 0631069
  • CAS-2114454
  • IDI1_000826
  • NCGC00015290-01
  • NCGC00016994-01
  • NCGC00016994-02
  • NCGC00016994-03
  • NCGC00016994-04
  • NCGC00016994-05
  • NCGC00016994-06
  • NCGC00016994-07
  • NCGC00016994-08
  • NCGC00016994-09
  • NCGC00016994-10
  • NCGC00016994-11
  • NCGC00016994-12
  • NCGC00016994-16
  • NCGC00016994-19
  • NCGC00016994-23
  • NCGC00016994-29
  • NCGC00024997-01
  • NCGC00024997-02
  • NCGC00024997-03
  • NCGC00024997-04
  • NCGC00024997-05
  • NCGC00024997-06
  • NCGC00178592-01
  • NCGC00178592-02
  • NCGC00261026-01
  • 1531628-77-9 (sodium camptothecin)
  • AJ-11194
  • AK-39842
  • AN-16065
  • BC203226
  • BR-39842
  • HY-16560
  • K332
  • NCI60_042105
  • SID:53789451
  • SMR000445686
  • SY010324
  • (S)-4-ethyl-4-hydroxy-1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • M01564
  • (S)-( )-Camptothecin, 98% - 1G 1g
  • AI3-62475
  • CPT
  • ST2412720
  • A2877
  • C1495
  • EU-0100341
  • FT-0777408
  • N1868
  • NS00011856
  • SW196414-3
  • TOPOTECAN RELATED COMPOUND C [USP-RS]
  • (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 21, 22-Secocamptothecin-21-oic acid lactone
  • A10174
  • C 9911
  • C01897
  • J10012
  • S-2515
  • (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
  • 32320-EP2270008A1
  • 32320-EP2272827A1
  • 32320-EP2275420A1
  • 32320-EP2277507A1
  • 32320-EP2277865A1
  • 32320-EP2280013A1
  • 32320-EP2281815A1
  • 32320-EP2286795A1
  • 32320-EP2286812A1
  • 32320-EP2289892A1
  • 32320-EP2292615A1
  • 32320-EP2292617A1
  • 32320-EP2295055A2
  • 32320-EP2295416A2
  • 32320-EP2298748A2
  • 32320-EP2298764A1
  • 32320-EP2298765A1
  • 32320-EP2298778A1
  • 32320-EP2301933A1
  • 32320-EP2305640A2
  • 32320-EP2305642A2
  • 32320-EP2305671A1
  • 32320-EP2308855A1
  • 32320-EP2311453A1
  • 32320-EP2311827A1
  • 32320-EP2311840A1
  • AB00052452-08
  • AB00052452-09
  • AB00052452_10
  • EN300-1725804
  • (S)-(+)-Camptothecin, >=90% (HPLC), powder
  • 157594-EP2277507A1
  • 157594-EP2286795A1
  • 179002-EP2280013A1
  • 689C034
  • A838882
  • D002166
  • Q419964
  • SR-01000075798
  • SR-01000597379
  • 251316-95-7
  • SR-01000075798-1
  • SR-01000075798-4
  • SR-01000597379-1
  • SR-01000597379-3
  • BRD-K37890730-001-09-4
  • BRD-K37890730-001-10-2
  • BRD-K37890730-001-15-1
  • BRD-K37890730-001-16-9
  • BRD-K37890730-001-17-7
  • (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
  • Z1741982070
  • 4-ETHYL-4-HYDROXY-1,12-DIHYDRO-4H-2-OXA-6,12A-DIAZA-DIBENZO[B,H]FLUORENE-3,13-DIONE
  • 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-
  • 251316-97-9
  • (S)-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
  • (4S)-4-ETHYL-4-HYDROXY-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE
  • (S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione
  • 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-
  • 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-
  • 4-Ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione
  • (S)-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]florene-3,13-dione
  • 4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 4-Ethyl-4-hydroxy-1H-pyrano-[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 4-Ethyl-4-hydroxy-1H-pyrano-[3[,4[:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • Topotecan Related Compound C, United States Pharmacopeia (USP) Reference Standard
  • (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
  • (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0(2),(1)(1).0?,?.0(1)?,(2)?]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
  • (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (4S)-4-Ethyl-4-hydroxy-1,4,12-trihydro-2-oxa-6,12a-diaza-13H-dibenzo[b,h]fluorene-3,13-dione
  • (4S)-4-Ethyl-4-hydroxy-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
  • (4S)-4-Ethyl-4-hydroxy-3,4-dihydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(12H,14H)-dione
  • (4S)-4alpha-Ethyl-4beta-hydroxy-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-4beta-Hydroxy-4-ethyl-3,4,12,13-tetrahydro-2-oxa-6,12a-diaza-1H-dibenzo[b,h]fluorene-3,13-dione
  • (S)-4-ethyl-4-hydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
  • (S)-4-ethyl-4-hydroxy-1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
  • (S)-4-ethyl-4-hydroxy-1H-pyrano-(3',4':6,7)indolozino(1,2-b)quinoline-3,14(4H,12H)-dione
  • (S)-4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 1480-64-4
  • 1H-Pyrano(3',3'.6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4hydroxy-(S)-
  • 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-
  • 1H-Pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-
  • 2086-83-1
  • 4(S)-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14 (4H,12H)-dione
  • 4-ethyl-4-hydroxy-(4S)-3,4,12,14-tetrahydro-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14-dione
  • 4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (camptothecin or CPT)
  • 4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (Camptothecin)
  • 4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (CPT, Camptothecin)
  • 4alpha-Ethyl-4beta-hydroxy-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 64439-81-2
  • 72517-83-0
  • EHD